Skip to main content

Published locations for FDA: No changes needed in management of ezogabine’s eye and skin effects

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA: No changes needed in management of ezogabine’s eye and skin effects

User login

  • Reset your password
  • /content/fda-no-changes-needed-management-ezogabines-eye-and-skin-effects
  • /edermatologynews/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye
  • /emed-journal/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye-and
  • /familypracticenews/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye
  • /ehospitalistnews/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye
  • /internalmedicinenews/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines
  • /internalmedicine/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye
  • /neurology/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye-and-skin
  • /dermatology/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye-and
  • /familymedicine/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye-and
  • /emergencymedicine/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines-eye
  • /clinicalneurologynews/article/100519/epilepsy-seizures/fda-no-changes-needed-management-ezogabines